WithdrawnPHASE1, PHASE2NCT02713984

A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer

Studying Gonadal germ cell tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zhi Yang
Principal Investigator
Cheng Qian, MD,PhD
Southwest Hospital, China
Intervention
Anti-HER2 CAR-T(biological)
Eligibility
18-80 years · All sexes
Timeline
2016 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02713984 on ClinicalTrials.gov

Other trials for Gonadal germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Gonadal germ cell tumor →

← Back to all trials